Gritstone bio Balance Sheet Health
Financial Health criteria checks 4/6
Gritstone bio has a total shareholder equity of $51.9M and total debt of $40.1M, which brings its debt-to-equity ratio to 77.4%. Its total assets and total liabilities are $177.8M and $125.9M respectively.
Key information
77.4%
Debt to equity ratio
US$40.14m
Debt
| Interest coverage ratio | n/a |
| Cash | US$79.27m |
| Equity | US$51.85m |
| Total liabilities | US$125.92m |
| Total assets | US$177.77m |
Recent financial health updates
Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?
Jul 07
We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate
Mar 05Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business
Nov 23Here's Why We're Not Too Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Situation
May 26Recent updates
Gritstone bio: GRANITE Cancer Vaccine Data Overshadowed By Offering
Apr 07Gritstone bio, Inc. (NASDAQ:GRTS) Analysts Just Slashed This Year's Revenue Estimates By 40%
Aug 14Gritstone bio: Early Data For SLATE Candidate Sets Up 2023 Catalyst
Sep 26Gritstone reaches six-month high on publication of data for cancer vaccine
Aug 16Gritstone bio announces $80M credit facility
Jul 21Is Gritstone bio (NASDAQ:GRTS) In A Good Position To Invest In Growth?
Jul 07Gritstone bio: Potential To Advance Colorectal Cancer Treatment
Jul 05Gritstone bio: Investing In A Premium mRNA Technology At A Discounted Valuation
Jun 14Some Analysts Just Cut Their Gritstone bio, Inc. (NASDAQ:GRTS) Estimates
Mar 17We're Not Very Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Rate
Mar 05Gritstone: Why The Stock Fell On Positive Data
Jan 18Gritstone bio (NASDAQ:GRTS) Is In A Strong Position To Grow Its Business
Nov 23Gritstone Poised To Dominate mRNA Market
Nov 08Here's Why We're Not Too Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Situation
May 26Gritstone Oncology EPS beats by $0.41, beats on revenue
May 06Financial Position Analysis
Short Term Liabilities: GRTS's short term assets ($87.4M) exceed its short term liabilities ($27.3M).
Long Term Liabilities: GRTS's short term assets ($87.4M) do not cover its long term liabilities ($98.6M).
Debt to Equity History and Analysis
Debt Level: GRTS has more cash than its total debt.
Reducing Debt: GRTS's debt to equity ratio has increased from 0% to 77.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GRTS has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: GRTS is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.